Actualités du secteur

Eurofins is pride to announce the acquisition of Dermscan Group, a well-recognised testing company with a global laboratory network.

During 28 years, Dermscan has built a significant reputation for excellence in safety, efficacy, clinical studies and in-vitro testing, serving the cosmetics, personal care, and pharmaceutical industries.

Eurofins is excited to strengthen its expertise in cosmetic testing in a market where the desire for safety and efficacy is among the highest in the world.

Dermscan brings to Eurofins Cosmetics innovative capabilities as well as strong competences from its worldwide expert team (France, Poland, Tunisia, Thailand and Mauritius).

In line with Eurofins Cosmetics' strategy to expand its leading global cosmetic testing footprint, this acquisition reinforces the position of Eurofins Cosmetics, with now on 40 state-of-the-art laboratories active in that field, across Europe, North America, Asia, Australia and Africa, offering an unmatched range of clinical, sensory, chemical, in-vitro and microbiological testing services to its clients.

"We are confident that this acquisition will contribute to the expansion of our expertise and footprint in the cosmetics testing industry by offering an increasingly wider scope of top-class services and facilitating the development of innovative new solutions for our customers" - explains Stéphane Barrau, VP Eurofins Consumer Product Testing.

Frédérique Girard-Ory, General Manager of Dermscan, comments: 
"This is a new adventure and a new challenge for the entire Dermscan's team that we are very excited to undertake. Joining Eurofins will enable us to propose an even more complete and diversified offer to the cosmetics industry."

About Dermscan

Established in 1990 and in continuous expansion ever since, Dermscan is headquarter in Lyon, France, and present today in Tunisia (Tunis), Poland (Gdansk), Thailand (Bangkok) and Mauritius (Quatre Bornes).

Dermscan has established a significant reputation for excellence in safety, efficacy and in-vitro testing and clinical studies, serving the cosmetics, personal care, and pharmaceutical industries in Europe, Asia and Africa, counting today with a broad international clients portfolio.[Sign up for your free email newsletter]The company employs over 150 highly skilled staff and is expected to generate revenues of over 12m EUR in 2018.

Source : cosmetics business
© 2018 Coeffiscience. Tous droits réservés. Conception & réalisation du site par HPJ.